The article for PMLiVE and Pharmaceutical Market Europe focuses on the transformations that data management and technology are bringing to the healthcare system, especially clinical research. Improvements in technology reduce errors and increase the immediacy and quality of data and researchers are better able to visualise patterns and trends, granting a real-time assessment of the safety of patients and trajectory of a trial. This aids medical decision-making and ensures more efficient studies.

 

Other improvements include the incorporation of Real-World Data and AI, which could save time and resources within trials. These advances support improved drug development and treatments being accepted into the market faster, ultimately benefitting patients. Regulators are adapting to these changes too, and are setting updated and clear criteria for the type of evidence they will accept during early-phase clinical research.

 

Continued advances in data management and data science will ensure that the general population will be able to benefit from new life-saving medications developed and integrated into the market faster and cheaper thanks to advances in data management.

 

To read the full article, click here

Latest news

Richmond Appoints Lisa Campbell as Director of Regulatory Strategy

April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read more

Von Willebrand Disease Trial – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol

April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read more

Events

Swiss Biotech Day 2025

5–6 May 2025
Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025
View event